F. Gilbert McMahon

439 total citations
7 papers, 295 citations indexed

About

F. Gilbert McMahon is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Analytical Chemistry. According to data from OpenAlex, F. Gilbert McMahon has authored 7 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Nephrology and 2 papers in Analytical Chemistry. Recurrent topics in F. Gilbert McMahon's work include Blood Pressure and Hypertension Studies (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Inflammatory mediators and NSAID effects (1 paper). F. Gilbert McMahon is often cited by papers focused on Blood Pressure and Hypertension Studies (3 papers), Analytical Methods in Pharmaceuticals (2 papers) and Inflammatory mediators and NSAID effects (1 paper). F. Gilbert McMahon collaborates with scholars based in United States. F. Gilbert McMahon's co-authors include Vincent DeQuattro, George L. Bakris, Adesh K. Jain, Jerome R. Ryan, Robert J. Noveck, Margo A. Smith, John H. Wilton, Aziz Karim, Prince K. Zachariah and David G. Sweet and has published in prestigious journals such as New England Journal of Medicine, JAMA and Kidney International.

In The Last Decade

F. Gilbert McMahon

7 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Gilbert McMahon United States	6	189	132	115	65	28	7	295
Gen Futaki Japan	4	186 1.0×	146 1.1×	160 1.4×	51 0.8×	23 0.8×	7	362
A J Apperloo Netherlands	6	235 1.2×	144 1.1×	194 1.7×	30 0.5×	28 1.0×	7	419
Beth A. Soffer United States	8	339 1.8×	214 1.6×	72 0.6×	92 1.4×	63 2.3×	9	514
Rafael Marín Spain	10	264 1.4×	77 0.6×	67 0.6×	18 0.3×	61 2.2×	12	404
Pascale Oddou-Stock Switzerland	9	417 2.2×	237 1.8×	66 0.6×	30 0.5×	28 1.0×	9	452
A DREISBACH United States	6	94 0.5×	72 0.5×	72 0.6×	20 0.3×	55 2.0×	6	335
A Mutsers Belgium	3	96 0.5×	87 0.7×	23 0.2×	46 0.7×	25 0.9×	5	208
J Tuomilehto Finland	9	215 1.1×	141 1.1×	22 0.2×	69 1.1×	72 2.6×	21	407
Domenic A. Sica United States	9	191 1.0×	69 0.5×	33 0.3×	23 0.4×	42 1.5×	19	308
Jan E. Heeg Netherlands	6	319 1.7×	171 1.3×	254 2.2×	57 0.9×	25 0.9×	7	529

Countries citing papers authored by F. Gilbert McMahon

Since Specialization

Citations

This map shows the geographic impact of F. Gilbert McMahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Gilbert McMahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Gilbert McMahon more than expected).

Fields of papers citing papers by F. Gilbert McMahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Gilbert McMahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Gilbert McMahon. The network helps show where F. Gilbert McMahon may publish in the future.

Co-authorship network of co-authors of F. Gilbert McMahon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Gilbert McMahon. A scholar is included among the top collaborators of F. Gilbert McMahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Gilbert McMahon. F. Gilbert McMahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bakris, George L., et al.. (1998). Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney International. 54(4). 1283–1289. 207 indexed citations

2.

Karim, Aziz, et al.. (1997). Oxaprozin and Piroxicam, Nonsteroidal Antiinflammatory Drugs with Long Half‐Lives: Effect of Protein‐Binding Differences on Steady‐State Pharmacokinetics. The Journal of Clinical Pharmacology. 37(4). 267–278. 19 indexed citations

3.

Sweet, C., et al.. (1991). 109. Efficacy and safety of oral MK-954 (DuP 753), an angiotensin receptor antagonist, in essential hypertension. Journal of Hypertension. 9. S469–S469. 9 indexed citations

4.

Zachariah, Prince K., et al.. (1988). Comparison of Quality of Life on Nitrendipine and Propranolol. Journal of Cardiovascular Pharmacology. 12. S29–S35. 14 indexed citations

5.

Jain, Adesh K., Jerome R. Ryan, & F. Gilbert McMahon. (1975). Potentiation of Hypoglycemic Effect of Sulfonylureas by Halofenate. New England Journal of Medicine. 293(25). 1283–1286. 14 indexed citations

6.

McMahon, F. Gilbert. (1975). Efficacy of an Antihypertensive Agent. JAMA. 231(2). 155–155. 4 indexed citations

7.

Jain, Adesh K., Jerome R. Ryan, F. Gilbert McMahon, & Robert J. Noveck. (1974). Effect of single oral doses of benzbromarone on serum and urinary uric acid. Arthritis & Rheumatism. 17(2). 149–157. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact